Our Team

Who we are

Our greatest asset

The leaders and advisors behind the NIMIA provide reliable, sensitive and clinically valid digital biomarkers that can be used in a totally unobtrusive manner, so as to detect and monitor continuously the disease activity in the preclinical and prodromal phase of MS.

Apparently, the multidisciplinary NIMIA team leverages the combined multifaceted expertise of top doctors in the field, experienced engineers, data scientists and researchers in this joint innovative endeavor.